Virginia Retirement Systems Et Al Athenex, Inc. Transaction History

Virginia Retirement Systems Et Al

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 21, 2021	SELL	$2.97 - $4.84 $45,738 - $74,536	-15,400 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$3.71 - $5.13 $371 - $513	100 Added 0.65%	15,400 $71,000
Q1 2021 Apr 30, 2021	SELL	$4.08 - $14.75 $11,424 - $41,300	-2,800 Reduced 15.47%	15,300 $66,000
Q4 2020 Feb 16, 2021	BUY	$11.06 - $14.01 $200,186 - $253,581	18,100 New	18,100 $200,000
Q2 2019 Jul 26, 2019	SELL	$9.44 - $19.8 $121,776 - $255,420	-12,900 Closed	0 $0
Q1 2019 Apr 25, 2019	BUY	$11.11 - $13.49 $143,319 - $174,021	12,900 New	12,900 $158,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.